OGN

Organon & Co

Price

$13.65

return (12m)

33.88%

p/e

-83.26

p/bv

3,703.22

DIVIDEND YIELD

0.58%

OGN price

Organon & Co

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment OGN

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-0.33%

3 months

1.53%

1 year

33.88%

2 years

0.00%

5 years

0.00%

10 years

0.00%

Profitability Comparator

If you had invested

years ago

ago, you would now have:

Fundamentals OGN

Valuation

P/E

-83.26

Sector 7.89

Industry 7.89

P/BV

3,703.22

Sector 1.90

Industry 1.90

P/Revenue (PSR)

0.82

Sector 1.84

Industry 1.84

EV/EBITDA

Sector -306.06

Industry -306.06

EV/EBIT

142.02

Sector -33,681,485.72

Industry -33,681,485.72

P/EBITDA

4.27

Sector -6.34

Industry -6.34

P/EBIT

4.78

Sector -7.33

Industry -7.33

P/Total Assets

282.70

Sector 0.89

Industry 0.89

P/Net Current Assets

-527.61

Sector -2.16

Industry -2.16

P/Working Capital

1,493.16

Sector -4,990.91

Industry -4,990.91

EPS

-0.17

Sector 0.73

Industry 0.73

BVPS

0.00

Sector 10.03

Industry 10.03

Efficiency

Gross Margin

52.51%

Sector 35.34%

Industry 35.34%

EBITDA Margin

Sector -7,057,929.62%

Industry -7,057,929.62%

EBIT Margin

5,515.21%

Sector -187.23%

Industry -187.23%

Operating Margin

18.80%

Sector 4.35%

Industry 4.35%

Net Profit Margins

-0.98%

Sector 2.73%

Industry 2.73%

Asset Turnover

0.12

Sector 0.11

Industry 0.11

Profitability

ROE

-4,447.91%

Sector 2.54%

Industry 2.54%

ROA

-339.55%

Sector -0.60%

Industry -0.60%

ROIC

Sector -115.70%

Industry -115.70%

Dividends

Dividend yield

0.58%

Sector 0.49%

Industry 0.49%

Payout

Sector 9.93%

Industry 9.93%

Debt

Current Ratio

1.95

Sector 1.46

Industry 1.46

Net Debt / EBITDA

Sector -20.13

Industry -20.13

Net Debt / EBIT

98.66

Sector -207,524,790.05

Industry -207,524,790.05

Net Debt / Equity

8,427.30

Sector -0.77

Industry -0.77

Gross Debt / Equity

8,428.43

Sector -0.51

Industry -0.51

Equity/Assets

0.08

Sector 0.43

Industry 0.43

Liabilities/Assets

0.92

Sector 0.53

Industry 0.53

Growth

5Y Revenue CAGR

-6.23%

Sector -

Industry -

5Y Earnings CAGR

0.00%

Sector -

Industry -

Fundamentals OGN

DRAG THE FRAME TO SEE MORE DATA

OGN Historical Dividends

current DY: 0.58%

5-year average DY: 0.84%

DRAG THE FRAME TO SEE MORE DATA

type	Ex - Dividend Date	payment date	value
Dividends	08/13/2026	09/10/2026	0.02000000
Dividends	05/08/2026	06/11/2026	0.02000000
Dividends	02/20/2026	03/12/2026	0.02000000
Dividends	11/19/2025	12/11/2025	0.02000000
Dividends	08/14/2025	09/11/2025	0.02000000
Dividends	05/09/2025	06/12/2025	0.02000000

ABOUT Organon & Co

Organon & Co

Average Investor10 user rating

4.0 (4 people)

United States

- year

Founded:

2021

Time since IPO - 5 years

10.000

Employees

Organon & Co (United States) is listed on the Nasdaq and has a market capitalization of $3.73 billion, with shareholders equity totaling $1.01 million.

The company employs approximately 10.000 people and operates in the Others sector, within the Others industry.

Over the past 12 months, Organon & Co reported $4.57 billion in revenue, generating net income of $-44.75 million.

Key financial metrics include a P/E ratio of -83.26, a price-to-book (P/B) ratio of 3,703.22, and a trailing twelve-month dividend yield of 0.58%.

The company trades under the ticker OGN.

Market cap

$3.73 billion

Net worth

$1.01 million

$1,006,000.00

Assets

$13.18 million

$13,178,000.00

Total Shares Outstanding

270.45 million

270,449,000

Average Daily Trading Volume

$8.17 million

$8,174,948.00

Sector

Others

Industry

Others

OGN

OGN revenue and profits

Financial Results OGN

DRAG THE FRAME TO SEE MORE DATA

OGN cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

UNH - UnitedHealth Group Incorporated

$377.19 10,16% (12M)

P/E

23.91

2.26%

ROE

14.27%

P/BV

3.41

SHEL - Shell PLC ADR

$96.48 40,33% (12M)

P/E

9.97

3.19%

ROE

14.29%

P/BV

1.42

STLA - Stellantis NV

$5.44 --43,13% (12M)

P/E

-0.63

0.00%

ROE

-35.93%

P/BV

0.23

COR - Cencora Inc.

$318.92 6,12% (12M)

P/E

24.46

0.72%

ROE

81.48%

P/BV

19.93

ALIZY - Allianz SE ADR

$51.26 --9,40% (12M)

P/E

14.43

2.60%

ROE

17.89%

P/BV

2.58

TTE - TotalEnergies SE ADR

$91.57 61,50% (12M)

P/E

7.11

4.58%

ROE

21.42%

P/BV

1.52

NSRGY - Nestle SA ADR

$95.00 7,02% (12M)

P/E

11.62

4.14%

ROE

58.05%

P/BV

6.75

ELV - Elevance Health Inc

$416.21 35,54% (12M)

P/E

19.53

1.73%

ROE

9.84%

P/BV

1.92